CIR
MRNA icon

Clear Investment Research’s Moderna MRNA Stock Holding History

Clear Investment Research’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-97
Closed -$4.93K – 151
2026
Q1 		$4.93K Buy
+97
New +$4.53K 0.01% 188
2025
Q4 		– Sell
-97
Closed -$2.51K – 162
2025
Q3 		$2.51K Hold
97
– – ﹤0.01% 214
2025
Q2 		$2.68K Buy
97
+29
+43% +$764 ﹤0.01% 191
2025
Q1 		$1.93K Buy
68
+29
+74% +$1.03K ﹤0.01% 192
2024
Q4 		$1.62K Hold
39
– – ﹤0.01% 195
2024
Q3 		$2.61K Buy
+39
New +$3.58K ﹤0.01% 186

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Clear Investment Research's MRNA Position: Q2 2026 in Review

Clear Investment Research sold out of Moderna (MRNA) in Q2 2026, closing a stake of 97 shares — an estimated $4.93K sold.

Clear Investment Research first reported a position in MRNA in Q3 2024 and held it in 6 quarters. The position peaked at $4.93K in Q1 2026. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Clear Investment Research reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Clear Investment Research sold 97 Moderna shares in Q2 2026, an estimated $4.93K.
  • Clear Investment Research first reported a position in Moderna in Q3 2024 and held it in 6 quarters.
  • Clear Investment Research's Moderna position peaked at $4.93K in Q1 2026.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Clear Investment Research's 13F filing for Q2 2026, filed 11 Aug 2026.